Prolactin response of NK cells, but not of LAK cells, is deficient in patients with carcinoma of oral cavity and during aging

International Journal of Cancer

Volumn 66, Issue 1, 1996, Pages 65-69

  Chakraborty, Abalokita ^a   Chakraborty, Nitya Gopal ^a   Chattopadhyay, Utpala ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; RECOMBINANT INTERLEUKIN 2;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADULT; AGED; AGING; CARCINOMA; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROLACTIN;

EID: 0029881074     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960328)66:1<65::AID-IJC12>3.0.CO;2-A     Document Type: Conference Paper

References (38)

1. BATORY, G., BENCZUR, M., VERGA, M., ONODY, C. and PETRANYI, G.G., Increased killer cell activity of aged humans, Immunobiology, 158, 393-398 (1981).
2. BAZAN, J.F., A novel family of growth factor receptor, a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptor and the p75 IL-2 receptor B-chain. Biochem. biophys. Res. Comm., 164, 788-795 (1989).
3. BERCZI, L, NAGY, E., DE TOLEDO, S.M., MATUSIK, R.J. and FRIESEN, H.G., Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue. J. Immunol., 146, 2201-2206 (1991).
4. BERNTON, E.W., Prolactin and immune host defenses. Progr. Neuroimmunoendoarinol., 2, 21-29 (1989).
5. BISWAS, R. and CHATTOPADHYAY, U., Altered prolactin response of the lymphocytes of tumor bearing mice. Int. J. Cancer, 50, 93-98 (1992).
6. CHAKRABORTY, A., CHAKRABORTY, N.G. and CHATTOPADHYAY, U., Age related natural killer activity of peripheral blood lymphocytes from healthy subjects and cancer patients. A comparative in vitro study with interleukin-2. Tumori, 80, 233-237 (1994).
7. CLEVENGER, C.V., RUSSELL, D.H., APPASAMY, P.M. and PRYSTOWSKY, M.B., Regulation of interleukin-2 driven T lymphocyte proliferation by prolactin. Proc. nat. Acad. Sct. (Wash), 87, 6460-6464 (1990).
8. DJIANE, J., CLAUSER, H. and KELL, P., Rapid down-regulation of prolactin receptors in mammary gland and liver. Biochem. biophys. Res. Comm.. 90, 1371-1379 (1979).
9. EURA, M., MAEHARA, T., IKAWA, T. and ISHIKAWA, T., Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients. Cancer Immunol. Immunother., 27, 147-153 (1988).
10. - (CD16) large granular lymphocytes and decreased NK activity during human aging. Clin. exp. Immunol., 68, 340-347 (1987).
11. FRANCESCHI, C., MONTI, D., SANSONI, P. and COSSARIZZA, A., The immunology of exceptional individuals: the lesson of centenarians. Immunol. Today, 16, 12-16 (1995).
12. GALA, R.R., Prolactin and growth hormone in the regulation of immune system. Proc. Soc. exp. Biol. Med., 198, 513-527 (1991).
13. GERLI, R., RAMBOTTI, P., NICOLETTI, I., ORLANDI, S., MIGLJORATI, G. and RICARDI, C., Reduced number of natural killer cells in patients with pathological hyperprolactinemia. Clin. exp. Immunol., 64, 399-406 (1986).
14. GONWA, T.A., WESTRICK, M.A. and MACHER, B.A., Inhibition of mitogen and antigen induced lymphocyte activation by human leukaemia cell ganglioside. Cancer Res., 44, 3467-3470 (1984).
15. HOMO-DELARCHE, F. and DURANT, S., Hormones, neutrotransmitters and neuropeptides as modulators of lymphocyte functions. In: I. Berczi and K. Kovacs (eds.), Immunopharmacology of epithelial barriers, pp. 171-240 (1994).
16. HOOGHE, R., DELHASE, M., VERGANI, P., MALUR, A., and HOOGHEPETERS, E.L., Growth hormone and prolactin are paracrine growth and differentiation factors in the haemopoietic system. Immunol. Today, 14, 212-214 (1993).
17. HORSEMAN, N.D. and Yu-LEE, L.Y., Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin and hematopoietic cytokines. Endocrine Rev., 15, 627-647 (1994).
18. ITOH, K., TILDEN, A.B., KLMAGI, K. and BALCH, C.M., Leu-IIlymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL-2)-induced activated killer (AK) cells. J. Immunol., 134, 802-807 (1985).
19. LIGTHART, G.J., SCHUIT, H.R. and HUMANS, W., Natural killer cell function is not diminished in the healthy aged and is proportional to the number of NK cells in the peripheral blood. Immunology. 68, 396-402 (1989).
20. LIN, C.C., KLO, Y.C., HUANG, W.C. and LIN, C.V., Natural killer cell activity in lung cancer patients. Chest, 92, 1022-1028 (1987).
21. LOTZOVA, E., SAVARY, C.A. and KEATING, M.T., Studies on the mechanism of defective natural killing in leukaemia diseased patients. Exp. Hematol. 10, 83-88 (1982).
22. MATERA, L., BELLONE, G. and CESANO, A., Prolactin and the neuroimmune network, Adv. Neuroimmunol., 1, 158-172 (1991).
23. MATERA, L., CESANO, A., MUCCIOLI, G. and VEGILA, F., Modulatory effect of prolactin on the DNA synthesis rate and NK activity of large granular lymphocytes. Int. J. Neuroscience, 51, 265-267 (1990).
24. MEITES, J., Aging: hypothalamic catecholamines, neuroendocrineimmune interactions, and dietary restriction. Proc. Soc. exp. Biol. Med., 195, 304-311 (1990).
25. NAGEL, J.E., CHOPRA, R.K., CHREST, F.J., MCCOY, M.T., SCHNEIDER, E.L., HOLBROOK, N.J. and ALDER, W.H., Decreased proliferation, interleukin-2 synthesis and interleukin-2 receptor expression are accompanied by decreased mRNA expression in phytohaemagghitinin stimulated cells from elderly donors. J. clin. Invest., 81, 106-1110 (1988).
26. ORSON, P.M., SADDEH, C.K., LEWIS, D.E. and NELSON, D.L., Interleukin-2 receptor expression by T ceils in human ageing. Cell. Immunol., 124, 278-291 (1989).
27. ORTALDO, J.R., MANON, A. and ORETON, R., Lymphokine activated killer cells. J exp. Med., 164, 1193-1205 (1986).
28. PARHAR, R.S. and LALA, P.K., Changes in the host natural killer cell population in mice during tumor development. Cell. Immunol., 93, 265-279 (1985).
29. PELLEGRINI, I., LEBRUN, J.J., ALI, S. and KELLY, P.A., Expression of prolactin and its receptor in human lymphoid cells. Mol. Endocrinol., 6, 1023-1031 (1992).
30. PROSS, H.F. and BAINES, M.G., Alterations in natural killer cell activity in tumor-bearing hosts. In: E. Lotzova and R.B. Herberman, (eds.), Immunobiology of natural killer cells, Vol. I, pp. 57-72 CRC Press. Boca Raton, FL. (1986).
31. ROSZMAN, T., ELLIOT, L. and BROOKS, W., Modulation of T cell functions by gliomas. ImmunoL Today. 12, 370-373 (1991).
32. ROTHSTEIN, G., Hematopoiesis in the aged: a model of hematopoietic dysregulation? Blood, 82, 2601-2604 (1993).
33. RUSSELL, D.H., KIBLER, R., MATRISIAN, L., LARSON, D.F., POULOS, B. and MAGUN, B.E., Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporin. J. Immunol., 134, 3027-3031 (1983).
34. SABHARWAL, P., GLASER, R., LAFUSE, W., VARMA, S., LIU, Q., ARKINS, S., KOOIJMAN, R., KUTZ, L., KELLEY, K.W. and MALARKEV, W B., Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc. nat. Acad. Sci. (Wash.), 89, 7713-7716 (1992).
35. SANSOM, P., COSSARIZZA, A., BRLANTI, V., FAGNONI, F., SNELLI, G., MONTI, D., MARCATO, A., PASSERI, G., ORTOLAM, C. and FORTI, E., Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood. 82, 2767-2773 (1993).
36. TAKAGI, S., KITAGAWA, S. and TAKEDA, A., Natural killer interferon system in patients with preleukaemic states. Brit. J. Haematol., 58, 71-75 (1984).
37. YOUNG, M.R., WHEELER, E. and NEWBY, M., Macrophage mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma. J. nat. Cancer Inst., 76, 745-749 (1986).
38. WILSON, A.B., HARRIS, J.M. and COOMBS, R.R., Interleukin-2 induced production of interferon by resting human T cells and large granular lymphocytes: requirement for accessory cell factors including interleukin-1. Cell. Immunol., 113, 130-142 (1988).